181 related articles for article (PubMed ID: 32640944)
1. Utility-Weighted Modified Rankin Scale Scores for the Assessment of Stroke Outcome: Pooled Analysis of 20 000+ Patients.
Wang X; Moullaali TJ; Li Q; Berge E; Robinson TG; Lindley R; Zheng D; Delcourt C; Arima H; Song L; Chen X; Yang J; Chalmers J; Anderson CS; Sandset EC
Stroke; 2020 Aug; 51(8):2411-2417. PubMed ID: 32640944
[TBL] [Abstract][Full Text] [Related]
2. Utility-weighted modified Rankin Scale: Still too crude to be a truly patient-centric primary outcome measure?
Rethnam V; Bernhardt J; Dewey H; Moodie M; Johns H; Gao L; Collier J; Ellery F; Churilov L;
Int J Stroke; 2020 Apr; 15(3):268-277. PubMed ID: 30747612
[TBL] [Abstract][Full Text] [Related]
3. Utility-Weighted Modified Rankin Scale as Primary Outcome in Stroke Trials: A Simulation Study.
Dijkland SA; Voormolen DC; Venema E; Roozenbeek B; Polinder S; Haagsma JA; Nieboer D; Chalos V; Yoo AJ; Schreuders J; van der Lugt A; Majoie CBLM; Roos YBWEM; van Zwam WH; van Oostenbrugge RJ; Steyerberg EW; Dippel DWJ; Lingsma HF;
Stroke; 2018 Apr; 49(4):965-971. PubMed ID: 29535271
[TBL] [Abstract][Full Text] [Related]
4. Health Utility Weighting of the Modified Rankin Scale: A Systematic Review and Meta-analysis.
Rebchuk AD; O'Neill ZR; Szefer EK; Hill MD; Field TS
JAMA Netw Open; 2020 Apr; 3(4):e203767. PubMed ID: 32347948
[TBL] [Abstract][Full Text] [Related]
5. Validation of the simplified modified Rankin scale for stroke trials: Experience from the ENCHANTED alteplase-dose arm.
Chen X; Li J; Anderson CS; Lindley RI; Hackett ML; Robinson T; Lavados PM; Wang X; Arima H; Chalmers J; Delcourt C;
Int J Stroke; 2021 Feb; 16(2):222-228. PubMed ID: 31969072
[TBL] [Abstract][Full Text] [Related]
6. Ethnicity and Other Determinants of Quality of Functional Outcome in Acute Ischemic Stroke: The ENCHANTED Trial.
Chen X; Wang X; Delcourt C; Li J; Arima H; Hackett ML; Robinson T; Lavados PM; Lindley RI; Chalmers J; Anderson CS;
Stroke; 2020 Feb; 51(2):588-593. PubMed ID: 31822251
[TBL] [Abstract][Full Text] [Related]
7. Adopting a Patient-Centered Approach to Primary Outcome Analysis of Acute Stroke Trials Using a Utility-Weighted Modified Rankin Scale.
Chaisinanunkul N; Adeoye O; Lewis RJ; Grotta JC; Broderick J; Jovin TG; Nogueira RG; Elm JJ; Graves T; Berry S; Lees KR; Barreto AD; Saver JL; ;
Stroke; 2015 Aug; 46(8):2238-43. PubMed ID: 26138130
[TBL] [Abstract][Full Text] [Related]
8. The combined impact of dependency on caregivers, disability, and coping strategy on quality of life after ischemic stroke.
Dewilde S; Annemans L; Lloyd A; Peeters A; Hemelsoet D; Vandermeeren Y; Desfontaines P; Brouns R; Vanhooren G; Cras P; Michielsens B; Redondo P; Thijs V
Health Qual Life Outcomes; 2019 Feb; 17(1):31. PubMed ID: 30732619
[TBL] [Abstract][Full Text] [Related]
9. How well do standard stroke outcome measures reflect quality of life? A retrospective analysis of clinical trial data.
Ali M; Fulton R; Quinn T; Brady M;
Stroke; 2013 Nov; 44(11):3161-5. PubMed ID: 24052510
[TBL] [Abstract][Full Text] [Related]
10. National Institutes of Health Stroke Scale: An Alternative Primary Outcome Measure for Trials of Acute Treatment for Ischemic Stroke.
Chalos V; van der Ende NAM; Lingsma HF; Mulder MJHL; Venema E; Dijkland SA; Berkhemer OA; Yoo AJ; Broderick JP; Palesch YY; Yeatts SD; Roos YBWEM; van Oostenbrugge RJ; van Zwam WH; Majoie CBLM; van der Lugt A; Roozenbeek B; Dippel DWJ;
Stroke; 2020 Jan; 51(1):282-290. PubMed ID: 31795895
[TBL] [Abstract][Full Text] [Related]
11. Statistical analysis plan for the EuroHYP-1 trial: European multicentre, randomised, phase III clinical trial of the therapeutic hypothermia plus best medical treatment versus best medical treatment alone for acute ischaemic stroke.
Winkel P; Bath PM; Gluud C; Lindschou J; van der Worp HB; Macleod MR; Szabo I; Durand-Zaleski I; Schwab S;
Trials; 2017 Nov; 18(1):573. PubMed ID: 29187242
[TBL] [Abstract][Full Text] [Related]
12. Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients.
Golicki D; Niewada M; Karlińska A; Buczek J; Kobayashi A; Janssen MF; Pickard AS
Qual Life Res; 2015 Jun; 24(6):1555-63. PubMed ID: 25425288
[TBL] [Abstract][Full Text] [Related]
13. Added Value of a Blinded Outcome Adjudication Committee in an Open-Label Randomized Stroke Trial.
van der Ende NAM; Roozenbeek B; Berkhemer OA; Koudstaal PJ; Boiten J; van Dijk EJ; Roos YBWEM; van Oostenbrugge RJ; Majoie CBLM; van Zwam W; Lingsma HF; van der Lugt A; Dippel DWJ;
Stroke; 2022 Jan; 53(1):61-69. PubMed ID: 34607469
[TBL] [Abstract][Full Text] [Related]
14. Can acute clinical outcomes predict health-related quality of life after stroke: a one-year prospective study of stroke survivors.
Yeoh YS; Koh GC; Tan CS; Lee KE; Tu TM; Singh R; Chang HM; De Silva DA; Ng YS; Ang YH; Yap P; Chew E; Merchant RA; Yeo TT; Chou N; Venketasubramanian N; Young SH; Hoenig H; Matchar DB; Luo N
Health Qual Life Outcomes; 2018 Nov; 16(1):221. PubMed ID: 30463574
[TBL] [Abstract][Full Text] [Related]
15. Very low quality of life after acute stroke: data from the Efficacy of Nitric Oxide in Stroke trial.
Sprigg N; Selby J; Fox L; Berge E; Whynes D; Bath PM;
Stroke; 2013 Dec; 44(12):3458-62. PubMed ID: 24149005
[TBL] [Abstract][Full Text] [Related]
16. Validity of the modified Rankin Scale in patients with aneurysmal subarachnoid hemorrhage: a randomized study.
Nobels-Janssen E; Postma EN; Abma IL; van Dijk JMC; de Ridder IR; Schenck H; Moojen WA; den Hertog MH; Nanda D; Potgieser ARE; Coert BA; Verhagen WIM; Bartels RHMA; van der Wees PJ; Verbaan D; Boogaarts HD
BMC Neurol; 2024 Jan; 24(1):23. PubMed ID: 38216872
[TBL] [Abstract][Full Text] [Related]
17. Health-related quality of life, anxiety and depression up to 12 months post-stroke: Influence of sex, age, stroke severity and atrial fibrillation - A longitudinal subanalysis of the Find-AF
Sadlonova M; Wasser K; Nagel J; Weber-Krüger M; Gröschel S; Uphaus T; Liman J; Hamann GF; Kermer P; Gröschel K; Herrmann-Lingen C; Wachter R
J Psychosom Res; 2021 Mar; 142():110353. PubMed ID: 33421630
[TBL] [Abstract][Full Text] [Related]
18. Phone and Video-Based Modalities of Central Blinded Adjudication of Modified Rankin Scores in an Endovascular Stroke Trial.
López-Cancio E; Salvat M; Cerdà N; Jiménez M; Codas J; Llull L; Boned S; Cano LM; Lara B; Molina C; Cobo E; Dávalos A; Jovin TG; Serena J;
Stroke; 2015 Dec; 46(12):3405-10. PubMed ID: 26542697
[TBL] [Abstract][Full Text] [Related]
19. Influence of Including Patients with Premorbid Disability in Acute Stroke Trials: The HeadPoST Experience.
Wang X; Moullaali TJ; Ouyang M; Billot L; Sandset EC; Song L; Delcourt C; Hackett ML; Watkins CL; Robinson TG; Yang J; Lavados PM; Brunser A; Olavarría VV; Muñoz-Venturelli P; Arima H; Middleton S; Pontes-Neto OM; Pandian JD; Rogers K; Anderson CS
Cerebrovasc Dis; 2021; 50(1):78-87. PubMed ID: 33434907
[TBL] [Abstract][Full Text] [Related]
20. Differences in psychometric properties, cut-off scores, and outcomes between the Barthel Index and Modified Rankin Scale in pharmacotherapy-based stroke trials: systematic literature review.
Balu S
Curr Med Res Opin; 2009 Jun; 25(6):1329-41. PubMed ID: 19419341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
